Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening
about
Screening for cervical cancer: when theory meets realityLow cost versus other screening tests to detect cervical cancer or precancer in developing countriesProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsChallenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006.Alternative technologies in cervical cancer screening: a randomised evaluation trial.Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data.Characterization of Molecular Markers Indicative of Cervical Cancer Progression.Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortiumThe influence of total hysterectomy in a cervical cancer screening population: a register-based cross-sectional studyLong-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study.High-grade cervical lesions among women attending a reference clinic in Brazil: associated factors and comparison among screening methods.50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence.Intense picosecond pulsed electric fields induce apoptosis through a mitochondrial-mediated pathway in HeLa cells.HPV catch-up vaccination of young women: a systematic review and meta-analysis.Worldwide burden of cervical cancer in 2008.Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007.Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test.Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)Small intestine metastasis from cervical cancer with acute abdomen: A case reportDifference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial.Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009Estimating the cost of cervical cancer screening in five developing countriesFollow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests.Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976-2005: an age-period-cohort analysisImpact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry studyPrimary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway.HPV-DNA testing for cervical cancer precursors: from evidence to clinical practiceAssessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.Beliefs, perceptions and health-seeking behaviours in relation to cervical cancer: a qualitative study among women in Uganda following completion of an HPV vaccination campaign.Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort studyChanges in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group.Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme.Viral infections and human cancers: the legacy of Denis Burkitt.The burden of HPV-associated anogenital cancers.Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania.
P2860
Q21261292-D7CB0246-AE26-45F0-8BAF-98352964E056Q24197577-0A314A3C-26A2-42CE-BC5E-B9ADB32DA212Q24202048-7ED4CE49-F6D8-4B92-8D58-9890D3D95845Q24235373-33D0AD47-C92B-43F0-A959-3E0D3939AC57Q30245295-61045F7A-BD27-4D9E-9625-75AF84B1B3B7Q30577708-702626C4-B480-43E4-BB9A-37589E0E02C1Q33260497-03EC85C1-49FA-4E71-8F7A-094883D6CB29Q33488158-C276EDBA-AE7A-4C05-AC67-0CB90A5C5F56Q33510920-CE5A9825-15E6-4F49-A369-DC5B8EE4DC4BQ33632477-5FAD3DA4-87E9-4909-BCD0-23159960A1F6Q33816398-8BDDACB9-F915-4D94-9C11-A6CD47157589Q33834332-78535298-BFE8-4F62-AAF8-576D8E7CEB53Q33890037-24658CD7-386C-448F-8F4C-ACF7F578A9F5Q34113534-F8A9B273-B7F6-40EF-AC0B-DCF8228ACDC6Q34151546-D0F95D67-A6CE-4357-A367-8AA226352200Q34157209-3838B699-E2B2-4829-A291-FAC0EC6DCF85Q34176394-35B81C8D-11C8-471B-BF27-2842E3A80CB5Q34240844-4F609F83-7B81-405F-82ED-ADBAC5EC7F7CQ34250191-4F3EA8D5-3747-45A3-8DB2-A03DBF298E56Q34286142-EAA743A7-0892-4790-8234-85D742AB6141Q34582539-A32992C2-0F3C-444A-B646-66811F354F3AQ34739688-F4387A34-031A-4C32-848C-947FDA73DC68Q34972824-DF3767E9-9926-40D4-B66F-6E82317E2058Q35039416-8761B63C-1561-4282-8DA1-3FEA1C7C9DFBQ35168212-D336A4C2-2AFC-4B9A-92E2-4D2F94693D76Q35287686-98F1B90C-464D-474D-8CE6-329B700B6B5CQ35700783-9917E846-0745-4BA3-BCA8-43008C4BD3E3Q35802505-C3DA8AB2-5343-4186-B84D-A572CD92FB7AQ35927132-C6180B48-5BB1-4008-B16E-D3C95FEE9ECBQ36071760-A006A2D5-BB76-4D08-94DF-CD6F1CEE26B9Q36183493-2D4A6B43-BCCE-403E-B6F4-C48F184D6613Q36596319-2F5C944B-BDAB-446E-95A8-FE6B0774584BQ37135912-AC71F27A-3C4E-4E10-A163-878B98B15131Q37247186-F7F37EFF-0C63-40AE-972B-CDADB72DD343Q37281710-B6B927A8-DC1E-410D-933B-83BB82F771BEQ37314466-05152D23-0EDC-4CED-99E2-1267A8F127F9Q37516596-DF4047D7-91C4-4C42-990A-6B9EE81B0854Q37974711-20E00795-A95C-4F45-A850-B687E150AF81Q38239507-8430C3A4-1FF1-4E1D-8B65-4D8CDA1ABCD5Q38444189-417DD510-6D9B-41F4-B94F-62E7B064E5C1
P2860
Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening
description
im März 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2005
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2005
@uk
name
Trends in Cervical Squamous Ce ...... k and the Effects of Screening
@en
Trends in Cervical Squamous Ce ...... k and the Effects of Screening
@nl
type
label
Trends in Cervical Squamous Ce ...... k and the Effects of Screening
@en
Trends in Cervical Squamous Ce ...... k and the Effects of Screening
@nl
prefLabel
Trends in Cervical Squamous Ce ...... k and the Effects of Screening
@en
Trends in Cervical Squamous Ce ...... k and the Effects of Screening
@nl
P2093
P50
P1476
Trends in cervical squamous ce ...... k and the effects of screening
@en
P2093
Anja H Loos
D Max Parkin
Mark Arbyn
Matti Hakama
Peter McCarron
P304
P356
10.1158/1055-9965.EPI-04-0569
P407
P577
2005-03-01T00:00:00Z